Temporal evolution of strut light intensity after implantation of bioresorbable polymeric intracoronary scaffolds in the ABSORB cohort b trial - An application of a new quantitative method based on optical coherence tomography

Circulation Journal

Volumn 78, Issue 8, 2014, Pages 1873-1881

  Nakatani, Shimpei ^a   Onuma, Yoshinobu ^a   Ishibashi, Yuki ^a   Eggermont, Jeroen ^b   Zhang, Yao Jun ^a   Campos, Carlos M ^a   Cho, Yun Kyeong ^a   Liu, Shengnan ^b   Dijkstra, Jouke ^b   Reiber, Johan H C ^b,c   Perkins, Laura ^d   Sheehy, Alexander ^d   Veldhof, Susan ^d   Rapoza, Richard ^d   van Es, Gerrit Anne ^a   Garcia Garcia, Hector M ^a   van Geuns, Robert Jan ^a   Serruys, Patrick W ^a,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Medis Medical Imaging Systems bv   (Netherlands)

^d ABBOTT VASCULAR   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bioresorbable vascular scaffold; Bioresorption; Coronary artery disease; Light intensity analysis; Optical coherence tomography

Indexed keywords

BIODEGRADABLE IMPLANT; BLOOD VESSEL PROSTHESIS; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HUMAN; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PHYSIOLOGIC MONITORING; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

ABSORBABLE IMPLANTS; BLOOD VESSEL PROSTHESIS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MONITORING, PHYSIOLOGIC; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84905032527     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0143     Document Type: Article

References (21)

1. Serruys PW, Garcia-Garcia HM, Onuma Y. From metallic cages to transient bioresorbable scaffolds: Change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 2012; 33: 16-25b.
2. Onuma Y, Serruys, PW, Bioresorbable scaffold: The advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011; 123: 779-797.
3. Raber L, Magro M, Stefanini GG, Kalesan B, van Domburg RT, Onuma Y, et al. Very late coronary stent thrombosis of a newergeneration everolimus-eluting stent compared with early-generation drug-eluting stents: A prospective cohort study. Circulation 2012; 125: 1110-1121.
4. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011; 57: 1314-1322.
5. Iqbal J, Onuma Y, Ormiston J, Abizaid A, Waksman R, Serruys P. Bioresorbable scaffolds: Rationale, current status, challenges, and future. Eur Heart J 2014; 35: 765-776.
6. Vorpahl M, Finn AV, Nakano M, Virmani R. The bioabsorption process: Tissue and cellular mechanisms and outcomes. EuroIntervention 2009; 5(Suppl F): F28-F35.
7. Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, Garcia-Garcia HM, et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: An attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation 2010; 122: 2288-2300.
8. Tearney GJ, Bouma BE. Shedding light on bioabsorbable stent struts seen by optical coherence tomography in the ABSORB trial. Circulation 2010; 122: 2234-2235.
9. Sheehy A, Gutierrez-Chico JL, Diletti R, Oberhauser JP, Glauser T, Harrington J, et al. In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis. EuroIntervention 2012; 7: 1227-1235.
10. Templin C, Meyer M, Muller MF, Djonov V, Hlushchuk R, Dimova I, et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: Comparison with light and electron microscopy. Eur Heart J 2010; 31: 1792-1801.
11. Serruys PW, Onuma Y, Garcia-Garcia HM, Muramatsu T, van Geuns RJ, de Bruyne B, et al. Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: A multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention 2014; 9: 1271-1284.
12. Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: Six-month clinical and imaging outcomes. Circulation 2010; 122: 2301-2312.
13. Okamura T, Garg S, Gutierrez-Chico JL, Shin ES, Onuma Y, Garcia-Garcia HM, et al. In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: An OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial. EuroIntervention 2010; 5: 932-938.
14. Gutierrez-Chico JL, van Geuns RJ, Regar E, van der Giessen WJ, Kelbaek H, Saunamaki K, et al. Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: An optical coherence tomography substudy from the RESOLUTE All Comers trial. Eur Heart J 2011; 32: 2454-2463.
15. Gomez-Lara J, Radu M, Brugaletta S, Farooq V, Diletti R, Onuma Y, et al. Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. JACC Cardiovasc Interv 2011; 4: 992-1001.
16. Gutierrez-Chico JL, Radu MD, Diletti R, Sheehy A, Kossuth MB, Oberhauser JP, et al. Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(Llactide) backbone of a bioresorbable vascular scaffold. Circ J 2012; 76: 342-350.
17. Radu MD, Onuma Y, Rapoza RJ, Diletti R, Serruys PW. In vivo visualisation by three-dimensional optical coherence tomography of stress crazing of a bioresorbable vascular scaffold implanted for treatment of human coronary stenosis. EuroIntervention 2012; 7: 1461-1463.
18. Fleiss J. The design and analysis of clinical experiments. New York: Wiley, 1986.
19. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009; 373: 897-910.
20. Ormiston JA, Serruys PW, Onuma Y, van Geuns RJ, de Bruyne B, Dudek D, et al. First serial assessment at 6 months and 2 years of the second generation of ABSORB everolimus-eluting bioresorbable vascular scaffold: A multi-imaging modality study. Circ Cardiovasc Interv 2012; 5: 620-632.
21. Gutierrez-Chico JL, Gijsen F, Regar E, Wentzel J, de Bruyne B, Thuesen L, et al. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: Evidence in vivo about the abluminal healing process. JACC Cardiovasc Interv 2012; 5: 428-435.